SV Health Investors closes science and healthcare fund
SV Health Investors, the venture capital and growth equity firm formerly known as SV Life Sciences, has closed on its sixth flagship fund at its target of USD400 million. SV also manages the Dementia Discovery Fund, plus five other funds that aim to support entrepreneurs and companies that create and